169 related articles for article (PubMed ID: 10770789)
41. Detection of borderline oxacillin-resistant Staphylococcus aureus and differentiation from methicillin-resistant strains.
Liu H; Buescher G; Lewis N; Snyder S; Jungkind D
Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):717-24. PubMed ID: 2261916
[TBL] [Abstract][Full Text] [Related]
42. Comparative efficacies of imipenem, oxacillin and vancomycin for therapy of chronic foreign body infection due to methicillin-susceptible and -resistant Staphylococcus aureus.
Schaad HJ; Chuard C; Vaudaux P; Rohner P; Waldvogel FA; Lew DP
J Antimicrob Chemother; 1994 Jun; 33(6):1191-200. PubMed ID: 7928812
[TBL] [Abstract][Full Text] [Related]
43. [Evaluation of susceptibility of methicillin resistant Staphylococcus aureus strains to vancomycin].
Młynarczyk G; Młynarczyk A; Meisel-Mikołajczyk F
Med Dosw Mikrobiol; 1995; 47(3-4):133-9. PubMed ID: 8833924
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of BD MAX Staph SR Assay for Differentiating Between Staphylococcus aureus and Coagulase-Negative Staphylococci and Determining Methicillin Resistance Directly From Positive Blood Cultures.
Lee J; Park YJ; Park DJ; Park KG; Lee HK
Ann Lab Med; 2017 Jan; 37(1):39-44. PubMed ID: 27834064
[TBL] [Abstract][Full Text] [Related]
45. Methicillin-resistant
Peixoto PB; Massinhani FH; Netto Dos Santos KR; Chamon RC; Silva RB; Lopes Correa FE; Barata Oliveira CDCH; Oliveira AG
J Med Microbiol; 2020 Jan; 69(1):41-45. PubMed ID: 31789588
[No Abstract] [Full Text] [Related]
46. Effect of vancomycin and teicoplanin alone or in combination with fusidic acid or amikacin against methicillin-resistant staphylococci.
Roussel-Delvallez M; Wallet F; Barbiery P; Courcol RJ
J Chemother; 1997 Feb; 9(1):5-8. PubMed ID: 9106011
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of the synergistic potential of vancomycin combined with other antimicrobial agents against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus spp strains.
Silva LV; Araújo MT; Santos KR; Nunes AP
Mem Inst Oswaldo Cruz; 2011 Feb; 106(1):44-50. PubMed ID: 21340354
[TBL] [Abstract][Full Text] [Related]
48. Susceptibility of clinical methicillin-resistant Staphylococci isolates to new antibiotics.
Oksuz L; Gurler N
J Infect Dev Ctries; 2013 Nov; 7(11):825-31. PubMed ID: 24240040
[TBL] [Abstract][Full Text] [Related]
49. In vitro activities of ampicillin-sulbactam and cefoperazone-sulbactam against oxacillin-susceptible and oxacillin-resistant staphylococci.
Barry AL; Jones RN
Antimicrob Agents Chemother; 1990 Sep; 34(9):1830-2. PubMed ID: 2285302
[TBL] [Abstract][Full Text] [Related]
50. The influence of salt concentration on the detection of methicillin resistance in coagulase-negative staphylococci.
Law D; Megson GM; Keaney MG; Ganguli LA
J Antimicrob Chemother; 1992 Nov; 30(5):603-14. PubMed ID: 1493978
[TBL] [Abstract][Full Text] [Related]
51. Synergistic Potential of Antimicrobial Combinations Against Methicillin-Resistant
Yu Y; Huang HL; Ye XQ; Cai DT; Fang JT; Sun J; Liao XP; Liu YH
Front Microbiol; 2020; 11():1919. PubMed ID: 33013731
[TBL] [Abstract][Full Text] [Related]
52. Methicillin resistance and biofilm production in clinical isolates of Staphylococcus aureus and coagulase-negative Staphylococcus in México.
García A; Martínez C; Juárez RI; Téllez R; Paredes MA; Herrera MDR; Giono S
Biomedica; 2019 Sep; 39(3):513-523. PubMed ID: 31584765
[TBL] [Abstract][Full Text] [Related]
53. Detection and expression of methicillin/oxacillin resistance in multidrug-resistant and non-multidrug-resistant Staphylococcus aureus in Central Sydney, Australia.
Merlino J; Watson J; Rose B; Beard-Pegler M; Gottlieb T; Bradbury R; Harbour C
J Antimicrob Chemother; 2002 May; 49(5):793-801. PubMed ID: 12003973
[TBL] [Abstract][Full Text] [Related]
54. Vancomycin-gentamicin synergism revisited: effect of gentamicin susceptibility of methicillin-resistant Staphylococcus aureus.
Mulazimoglu L; Drenning SD; Muder RR
Antimicrob Agents Chemother; 1996 Jun; 40(6):1534-5. PubMed ID: 8726033
[TBL] [Abstract][Full Text] [Related]
55. Synergistic antibacterial effects of herbal extracts and antibiotics on methicillin-resistant Staphylococcus aureus: A computational and experimental study.
Kuok CF; Hoi SO; Hoi CF; Chan CH; Fong IH; Ngok CK; Meng LR; Fong P
Exp Biol Med (Maywood); 2017 Apr; 242(7):731-743. PubMed ID: 28118725
[TBL] [Abstract][Full Text] [Related]
56. Activity of oritavancin against methicillin-resistant staphylococci, vancomycin-resistant enterococci and β-haemolytic streptococci collected from western European countries in 2011.
Morrissey I; Seifert H; Canton R; Nordmann P; Stefani S; Macgowan A; Janes R; Knight D;
J Antimicrob Chemother; 2013 Jan; 68(1):164-7. PubMed ID: 22941898
[TBL] [Abstract][Full Text] [Related]
57. In vitro activity of antimicrobial agents against oxacillin resistant staphylococci with special reference to Staphylococcus haemolyticus.
Chaudhury A; Kumar AG
Indian J Med Microbiol; 2007 Jan; 25(1):50-2. PubMed ID: 17377353
[TBL] [Abstract][Full Text] [Related]
58. In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide clinical isolates of staphylococci.
Auckenthaler R; Courvalin P; Féger C; Roche G;
Clin Microbiol Infect; 2000 Nov; 6(11):608-12. PubMed ID: 11168064
[TBL] [Abstract][Full Text] [Related]
59. High-level oxacillin and gentamycin resistance with reduced susceptibility to vancomycin in Staphylococcus aureus-carrying mecA and femA gene complex.
Raju S; Kelmani Chandrakanth R; Patil SA
Curr Microbiol; 2007 Jun; 54(6):429-34. PubMed ID: 17457646
[TBL] [Abstract][Full Text] [Related]
60.
Mohammadi-Berenjestanaki H; Khori V; Shirzad-Aski H; Ghaemi EA
Microb Drug Resist; 2020 Mar; 26(3):218-226. PubMed ID: 31424323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
